Cyclerion Therapeutics Inc Revenue per Employee (CYCN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cyclerion Therapeutics Inc   (NASDAQ: CYCN)
 

Cyclerion Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Cyclerion Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,900,000, below the company average number of $3,239,846.
Within the Healthcare sector Cyclerion Therapeutics Inc achieved the highest revenue per employee. While revenue/employee total ranking has improved so far to 1, from total ranking in previous quarter at 533. Cyclerion Therapeutics Inc has 1 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYCN Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change - - -43.24 % 351.03 % -
Sales per Employee (TTM) $ 1,900,000 1,993,000 2,074,000 2,855,000 2,174,000
CYCN's Total Ranking # 1 # 533 # 314 # 397 #
Seq. Revenue Change - - 17.14 % 840.86 % 14.81 %

CYCN Company Profile >> Back to CYCN Efficiency Comparisons >> Compare CYCN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market # 1

Revenue per Employee Statistics
High Average Low
$ 5,521,000 $ 3,239,846 $ 1,344,000
(Mar 31 2020)   (Mar 31 2021)



Financial Statements
Cyclerion Therapeutics Inc 's Revenue MRQ $ 0 Millions Visit CYCN's Income Statement
Cyclerion Therapeutics Inc 's Revenues TTM $ 2 Millions Visit CYCN's aggregate revenue growth
What are CYCN's Sales? Visit CYCN's Sales by Segment




Other Ratios
Cyclerion Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CYCN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CYCN's Competitors
Revenue per Employee for CYCN's Suppliers
Revenue per Employee for CYCN's Customers

You may also want to know
CYCN's Sales Growth Rates CYCN's Pe Price to earnings ratio CYCN's Receivables Turnover Ratio CYCN's Stock Quote
CYCN's Net Income Growth Rates CYCN's Ps Price to Sales ratio CYCN's Sales per Employee CYCN's Asset Turnover Ratio
CYCN's Net Margin CYCN's Pb Price to Book ratio CYCN's Financial Strength Ratios CYCN's Dividend Payout Ratio
Date modified: 2026-08-13T21:11:50+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Harmony Biosciences Holdings inc   3,277,102.39 $ 960.191  Million 293 
Therapeuticsmd Inc   3,270,000.00 $ 3.270  Million 1 
Amgen Inc   2,930,384.62 $ 38,095.000  Million 13,000 
Innoviva Inc   2,645,471.70 $ 420.630  Million 159 
Aurinia Pharmaceuticals Inc   2,433,648.44 $ 311.507  Million 128 
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Sarepta Therapeutics Inc   2,364,483.83 $ 1,974.344  Million 835 
United Therapeutics Corporation  2,253,214.29 $ 3,154.500  Million 1,400 
Biocryst Pharmaceuticals Inc   2,162,328.74 $ 940.613  Million 435 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Protagonist Therapeutics inc   2,136,303.03 $ 281.992  Million 132 
Exelixis Inc   2,123,731.47 $ 2,435.920  Million 1,147 
Zevra Therapeutics Inc   2,112,377.05 $ 128.855  Million 61 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Tg Therapeutics Inc   2,003,849.62 $ 799.536  Million 399 
Prestige Consumer Healthcare Inc   1,938,521.05 $ 1,104.957  Million 570 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 
Alnylam Pharmaceuticals Inc   1,921,672.80 $ 4,804.182  Million 2,500 
Gilead Sciences Inc   1,791,588.24 $ 30,457.000  Million 17,000 
Collegium Pharmaceutical Inc   1,777,172.58 $ 751.744  Million 423 
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Mirum Pharmaceuticals Inc   1,661,470.43 $ 618.067  Million 372 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 
Agenus Inc  1,638,185.19 $ 132.693  Million 81 
Xenetic Biosciences Inc   1,630,388.50 $ 3.261  Million 2 
Ideaya Biosciences Inc   1,614,668.97 $ 234.127  Million 145 
Eli Lilly And Company  1,593,316.00 $ 79,665.800  Million 50,000 
Jazz Pharmaceuticals Plc  1,592,122.15 $ 4,601.233  Million 2,890 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.